A Mount Sinai researcher has founded a regional research consortium to pool the work of some of the top labs in the field to promote a better understanding of CFTR, a protein implicated in cystic fibrosis, and how it could lead to new therapies for lung infections. Jaime Hook, MD, sees great value in the exchange of ideas and information among members of the relatively small lung research community that could push the boundaries of CFTR science.